Home > Healthcare > Biotechnology > Bioservices > Whole Genome Sequencing Market

Whole Genome Sequencing Market Share

Report ID: GMI6932
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Whole Genome Sequencing Market Share

Within the whole genome sequencing industry, major industry players along with small and mid-size companies compete to offer advanced services in this space. Illumina, Inc, Thermo Fisher Scientific, Inc, and Danaher Corporation accounts for largest market share in the overall market. By meticulously assessing the market share of company considering factors such as the breadth of service offerings and customer satisfaction, one can unveil valuable insights into the competitive landscape of this market and strategically position themselves for success in this sector.

Major players operating in the whole genome sequencing is as mentioned below:

Thermo Fisher Scientific, Inc
Danaher Corporation
Illumina, Inc
QIAGEN N.V.
Merck KGaA
Eurofins Scientific
Siemens Healthineers
Macrogens, Inc
Bio-Rad Laboratories, Inc
Agilent Technologies, Inc
F. Hoffmann-La Roche Ltd

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The whole genome sequencing (WGS) market size was valued to be USD 5.5 billion in 2022 and is expected to surpass USD 30 billion by 2032 driven by increasing prevalence of genetic disorders.

The consumables segment is expected to reach USD 18.1 billion by 2032, due to the use of consumables in large quantities in every step of the sequencing process.

In 2022, North America whole genome sequencing market was valued at USD 2.5 billion and will continue to grow, is majorly attributed to the increasing research institutions, universities, and medical centers in the region.

Thermo Fisher Scientific, Inc, Danaher Corporation, Illumina, Inc, QIAGEN N.V., Merck KGaA, Eurofins Scientific, Siemens Healthineers, Macrogens, Inc, Bio-Rad Laboratories, Inc, Agilent Technologies, Inc, and F. Hoffmann-La Roche Ltd.